Dyanavel XR (amphetamine) for ADHD

Dyanavel XR (amphetamine) for ADHD

0 out of 5


9223372036854775807 in stock

SKU: Dyanavel XR (amphetamine) Category:PRESCRIPTION DRUGS


Buy Generic Dyanavel® XR (amphetamine) CII Online – POWERALL PHARMACY

Generic Dyanavel XR Amphetamine Extended-release Oral Suspension For Sale Online

Order Dyanavel XR At Low Rate Prices and Dyanavel XR Coupons – POWERALL PHARMACY

Purchase Generic Dyanavel XR (amphetamine) Online for ADHD Treatment in USA, UK & CA

Where & How To Get Generic Dyanavel XR (amphetamine) Online Safely Nowadays

DYANAVEL XR (amphetamine) extended release oral suspension, a CNS stimulant, is an extended-release liquid formulation containing a 3.2 to 1 ratio of d- to l-amphetamine.

Each 1 mL of DYANAVEL XR contains 2.5 mg of amphetamine which is the same as the amount of amphetamine (base equivalent) found in a 4 mg strength amphetamine mixed salts product.

DYANAVEL XR (amphetamine) Structural Formula Illustration

DYANAVEL XR utilizes an ion exchange resin where the drug is bound to the resin (sodium polystyrene sulfonate) through an ionic binding reaction. DYANAVEL XR contains immediate release and extended-release components. The extended-release component is coated with an aqueous, pH-independent polymer. After drug release the ion-exchange resin is excreted in the feces.

Inactive Ingredients: anhydrous citric acid, bubblegum flavor, glycerin, methylparaben, modified food starch, polysorbate 80, povidone, polyvinyl acetate, propylparaben, sodium lauryl sulfate, sodium polystyrene sulfonate, sucralose, triacetin and xanthan gum.

DYANAVEL XR is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies].


Important Information Prior To Initiating Treatment
Prior to treating children, adolescents, and adults with CNS stimulants, including DYANAVEL XR, assess for the presence of cardiac disease (i.e., perform a careful history, family history of sudden death or ventricular arrhythmia, and physical exam) [see WARNINGS AND PRECAUTIONS].
Assess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while on therapy. Maintain careful prescription records, educate patients about abuse, monitor for signs of abuse and overdose, and periodically re-evaluate the need for DYANAVEL XR use [see PRECAUTIONS, and Drug Abuse and Dependence].

General Dosing Information

DYANAVEL XR should be orally administered once daily in the morning with or without food. The dose should be individualized according to the needs and responses of the patient. Before administering the dose, shake the bottle of DYANAVEL XR.
In children 6 years of age and older, start with 2.5 mg or 5 mg once daily in the morning. The dose may be increased in increments of 2.5 mg to 10 mg per day every 4 to 7 days up to a maximum dose of 20 mg per day.
Pharmacological treatment of ADHD may be needed for extended periods. Healthcare providers should periodically re-evaluate the long-term use of DYANAVEL XR, and adjust dosage as needed.

Dosage Forms And Strengths

Extended-release oral suspension contains 2.5 mg amphetamine base per mL.
DYANAVEL XR (amphetamine) extended-release oral suspension, the concentration is 2.5 mg/mL amphetamine base and is supplied as light beige to tan viscous suspension with bubblegum flavor in bottles of 464 mL (NDC 27808-102-01).

Storage And Handling

Dispense in a tight container with child-resistant closure.
Store at 20° to 25°C (68° to 77°F); excursions permitted from 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. The pharmacist should provide an oral dosing syringe or other suitable measuring device.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.